Table 2.
Raw Intensity Valueb | ||||||||
---|---|---|---|---|---|---|---|---|
miRNA Probea |
AFP >2000ng/ulc |
AFP <20ng/uld |
Fold Change |
Parametric p-value |
FDR | Chromosome Location |
Gain (%)e |
Loss (%)e |
miR-29a (1) | 1230.14 | 2193.45 | 0.56 | < 0.00001 | 0.0001 | 7q32 | 6.6 | 1.3 – 2.6 |
miR-29a (2) | 1542.24 | 2730.72 | 0.56 | < 0.00001 | 0.0004 | 7q32 | 6.6 | 1.3 – 2.6 |
miR-29b-2 | 1756 | 3106.81 | 0.57 | < 0.00001 | 0.0001 | 1q32 | 34.2 | 1.3 |
miR-29b-1 (1) | 1477.04 | 2545.82 | 0.58 | < 0.00001 | 0.0004 | 7q32 | 6.6 | 1.3 – 2.6 |
miR-122a (1) | 16063.12 | 27088.34 | 0.59 | < 0.00001 | 0.0059 | 18q21 | 0 | 6.6 |
miR-29b-1 (2) | 1377.04 | 2242.49 | 0.61 | < 0.00001 | 0.0100 | 7q32 | 6.6 | 1.3 – 2.6 |
miR-29b-1 (2) | 960.32 | 1559.23 | 0.62 | < 0.00001 | 0.0040 | 7q32 | 6.6 | 1.3 – 2.6 |
miR-29c | 1418.1 | 2247.65 | 0.63 | < 0.00001 | 0.0059 | 1q32 | 34.2 | 1.3 |
miR-125b-1 (1) | 1613.31 | 2482.49 | 0.65 | 0.00110 | 0.0328 | 11q24 | 1.3 | 6.6 |
miR-125b-1 (2) | 1448.15 | 2194.68 | 0.66 | 0.00120 | 0.0315 | 11q24 | 1.3 | 6.6 |
miR-122a (2) | 29564.15 | 40839.46 | 0.72 | 0.00070 | 0.0250 | 18q21 | 0 | 6.6 |
miR-let-7d | 1116.67 | 1429.47 | 0.78 | 0.00030 | 0.0233 | 9q22 | 2.6 | 13.2 |
miR-let-7f | 679.58 | 862.59 | 0.79 | 0.00060 | 0.0250 | 9q22 | 2.6 | 13.2 |
miR-181b-2 (1) | 2216.1 | 1622.01 | 1.37 | 0.00010 | 0.0059 | 9q33 | 5.3 | 10.5 |
miR-181c | 1279.19 | 930.72 | 1.37 | 0.00010 | 0.0093 | 19q13 | 9.2 – 10.5 | 3.9 |
miR-181b-1 | 1807.52 | 1193.32 | 1.51 | 0.00010 | 0.0044 | 1q32 | 34.2 | 1.3 |
miR-181b-2 (2) | 2289.77 | 1470.03 | 1.56 | < 0.00001 | 0.0001 | 9q33 | 5.3 | 10.5 |
miR-32 | 1891.71 | 1143.94 | 1.65 | 0.00010 | 0.0059 | 9q31 | 2.6 | 13.2 |
The miRNA array includes multiple spots for some miRNAs therefore there are multiple probe readouts. Additional probes for miRNAs are numbered in parenthesis after the probe name.
Mean values for miRNA expression are shown for AFP high and normal cases and were used to calculate fold change.
High AFP, n=40
Low AFP, n=74
Percent gain and loss were estimated by copy-number variation (CNV) data from 36 HCC tumor tissue samples. In cases where the miRNA is not in a gene, the genes upstream and downstream of the miRNA were used to estimate CNV.